VLON - Vallon Pharmaceuticals names Leanne Kelly as chief financial officer

Vallon Pharmaceuticals (VLON) announces the appointment of Leanne Kelly as the company's chief financial officer.Kelly is a financial executive with over 20 years of experience leading private and publicly traded companies across life science, technology and e-Commerce sectors and a foundation in public accounting.Prior to joining Vallon, she most recently served as the Controller and Executive Director, Global Financial Reporting at OptiNose.Shares down nearly 2% premarket.

For further details see:

Vallon Pharmaceuticals names Leanne Kelly as chief financial officer